Clinical Trial Update: Romosozumab/Denosumab Study for Premenopausal IOP [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Columbia University is evaluating the combination of romosozumab and denosumab for premenopausal idiopathic osteoporosis, and the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premenopausal Idiopathic Osteoporosis

Drugs mentioned

• Evenity (romosozumab)
• Prolia (denosumab)

Snippet

Sponsor: Columbia University | Conditions: Premenopausal Idiopathic Osteoporosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING